| pubmed-article:9255225 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C0023418 | lld:lifeskim |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C0169964 | lld:lifeskim |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
| pubmed-article:9255225 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:9255225 | pubmed:issue | 1 Pt 2 | lld:pubmed |
| pubmed-article:9255225 | pubmed:dateCreated | 1997-9-4 | lld:pubmed |
| pubmed-article:9255225 | pubmed:abstractText | Data have suggested that any increased incidence of leukemia in growth-hormone (GH)-treated patients was limited to those with known risk factors for leukemia. However, previous studies may have overestimated the numbers of patient-years of risk by not excluding data from "positive-risk-factor" patients. This risk was reanalyzed by using data on children in the National Cooperative Growth Study (NCGS), with correction for this possible confounding factor. | lld:pubmed |
| pubmed-article:9255225 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9255225 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9255225 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9255225 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9255225 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9255225 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9255225 | pubmed:issn | 0022-3476 | lld:pubmed |
| pubmed-article:9255225 | pubmed:author | pubmed-author:AllenD BDB | lld:pubmed |
| pubmed-article:9255225 | pubmed:author | pubmed-author:GravesD ADA | lld:pubmed |
| pubmed-article:9255225 | pubmed:author | pubmed-author:BlethenS LSL | lld:pubmed |
| pubmed-article:9255225 | pubmed:author | pubmed-author:RundleA CAC | lld:pubmed |
| pubmed-article:9255225 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9255225 | pubmed:volume | 131 | lld:pubmed |
| pubmed-article:9255225 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9255225 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9255225 | pubmed:pagination | S32-6 | lld:pubmed |
| pubmed-article:9255225 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:meshHeading | pubmed-meshheading:9255225-... | lld:pubmed |
| pubmed-article:9255225 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9255225 | pubmed:articleTitle | Risk of leukemia in children treated with human growth hormone: review and reanalysis. | lld:pubmed |
| pubmed-article:9255225 | pubmed:affiliation | Department of Pediatrics, University of Wisconsin Medical School, Madison, USA. | lld:pubmed |
| pubmed-article:9255225 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9255225 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9255225 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9255225 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9255225 | lld:pubmed |
